Intrinsic Value of S&P & Nasdaq Contact Us

NeuroMetrix, Inc. NURO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NURO

NeuroMetrix, Inc. (NURO) has a market capitalization of $9.43M and trades at $4.58. The 52-week range is 2.66-4.73.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.2, Earnings Per Share (EPS) of $-3.96, annual revenue of $3.03M.

The stock has a beta of 1.84, operates in the Healthcare sector.

Trading Data
Current Price$4.58
52-Week Range2.66-4.73
Volume35.59K
Avg Volume (30D)11.5K
Market Cap$9.43M
Beta (1Y)1.84
Company
IPO Date2004-07-22
Employees13
CEOShai N. Gozani
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS6412558800
CUSIP641255807
Income (Latest Year)
Revenue$3.03M
Gross Profit$1.68M
EBITDA$-8.78M
Operating Income$-8.78M
Net Income$-7.81M
EPS$-3.96
EPS Diluted$-3.96
Shares Outstanding$1.97M
Balance Sheet (Latest Year)
Total Assets$15.32M
Current Assets$15.01M
Cash & ST Investments$13.1M
Total Liabilities$1.01M
Total Debt$107.35K
Net Debt$-1.32M
Total Equity$14.31M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-1.2
P/S Ratio3.11
P/B Ratio0.66
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message